Navigation Links
NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG)

SAN CARLOS, Calif., June 07, 2007 /PRNewswire-FirstCall/ -- NeurogesX, Inc. announced today the presentation of clinical data from a positive Phase 3 trial in postherpetic neuralgia (PHN). Misha-Miroslav Backonja, M.D., Professor of Neurology at University of Wisconsin in Madison and lead academic investigator in the NeurogesX trial, plans to present the results of the study in a June 8 poster session at the Second International Congress on Neuropathic Pain in Berlin, Germany. Dr. Backonja's poster presentation is based on an abstract titled, "Localized Treatment with NGX- 4010 Significantly Reduced Pain for up to 12 Weeks: Results of A Randomized, Double-Blind, 12-Week Controlled Study in Postherpetic Neuralgia Patients."

The study evaluated the effect of a single application of NGX-4010, the Company's novel dermal patch, on pain due to PHN. The primary endpoint in this Phase 3 trial was achieved, demonstrating a statistically significant reduction in pain over an 8-week period (NGX-4010, -29.6% vs. control, -19.9%; p = 0.001). The reduction of pain was sustained over 12 weeks (NGX-4010, -29.9% vs. control, -20.4%; p=0.0016).

"The results of this pivotal Phase 3 trial demonstrate NGX-4010 is effective both alone and in combination with other neuropathic pain medications for the treatment of PHN," said Dr. Backonja. "We believe that NGX-4010's unique profile has the potential to provide a meaningful therapeutic alternative to traditional therapies that need to be taken daily, most of which have systemic side effects."

According to the Centers for Disease Control, there are approximately 1.0 million cases of shingles in the United States each year, and approximate one in five shingles sufferers go on to develop PHN. People with PHN experience pain and increased sensitivity of the skin that can persist for many years.

NeurogesX plans to complete a confirmatory Phase 3 trial in PHN in t
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/18/2014)... LA JOLLA, Calif. , Sept. 18, 2014 ... RGLS ), a biopharmaceutical company leading the ... announced today it has initiated its ATHENA natural ... syndrome, a life-threatening genetic kidney disease with no ... characterize the natural decline of renal function markers ...
(Date:9/18/2014)...   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... announced the first presentation of positive safety and ... Investigation of Collagenase Optimizing the Resolution of Dupuytrens) ... histolyticum (CCH) for the treatment of two Dupuytren,s ... the study examined expanded flexibility with timing of ...
(Date:9/18/2014)... Russia is currently experiencing a ... to deteriorate further as a result of the newly imposed ... the form of decreasing domestic demand, a weaker rouble exchange ... and international capital outflow. Exporters to ... and defaults. Some sectors are expected to be more affected ...
Breaking Medicine Technology:Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 7Exporters to Russia Facing Increasing Payment Risk 2
... , BEDFORD, Mass., Aug. 19 Holo ... (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of ... healthcare needs of women, today announced the publication of the first of ... both symptomatic and asymptomatic pregnant women at risk for preterm birth. The ...
... , JAMESBURG, N.J., Aug. 19 Phytomedics Inc. today ... 2b clinical trial with an extract of Tripterygium wilfordii Hook F ... in the August 18, 2009 issue of the Annals of Internal ... article entitled "Comparison of Tripterygium wilfordii Hook F versus ...
Cached Medicine Technology:Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 2Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 3Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 4Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis 2Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis 3
(Date:9/18/2014)... Texas Physical Therapy Specialists (TexPTS) is proud ... Physicians Association (HPA) Friends and Family Golf tournament ... The tournament, which will take place at TopGolf from ... scholarships through three golf challenges, “Top Scramble”, “Top Score”, ... is provided at the event and there will be ...
(Date:9/18/2014)... 18, 2014 After years of shooting at ... firing range berms were saturated with lead, which increased the ... in the berm and send metal fragments back at the ... splashback, and the greater the potential for injury to officers. ... to remove lead from the range environment. , ...
(Date:9/18/2014)... 18, 2014 Sutter Health’s California Pacific ... of Dolby Laboratories, by naming the Ray Dolby Brain ... Ray Dolby provided a founding gift of $21 million ... provides services to patients and families suffering from Alzheimer’s, ... have been treated at the center since its opening ...
(Date:9/18/2014)... On August 23, the HearStrong Foundation ... Service Award for his contributions to the deaf and ... Retired Players Association (NBRPA) Legends World Sports Conference in ... in 1977, Glenn would go on to play for ... Hawks, and the Milwaukee Bucks throughout his ten-year career ...
(Date:9/18/2014)... MD Complete , the breakthrough ... prescription, announced today that SHAPE Magazine has named ... Peel” in its annual Beauty Awards. The issue is ... products as tested by SHAPE’s expert team. , SHAPE ... Among the thousands of beauty products launched every year, ...
Breaking Medicine News(10 mins):Health News:Texas Physical Therapy Specialists Sponsoring HPA Friends & Family Golf Tournament 2Health News:Firing Range Safety is Ohio DOC Priority 2Health News:Firing Range Safety is Ohio DOC Priority 3Health News:Sutter Health’s CPMC announces Ray Dolby Brain Health Center 2Health News:Sutter Health’s CPMC announces Ray Dolby Brain Health Center 3Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 2Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 3Health News:MD Complete Wins Shape Beauty Award for Best Peel 2
... Accounts; Membership in ECP Global Communication International NetworkNEW ... www.feintuchcommunications.com ), a strategic relations firm ... Feintuch, has opened for business with offices at ... http://www.newscom.com/cgi-bin/prnh/20090406/NY94367LOGO )Mr. ...
... for Medical Benefits, Movement to Direct Contracting for ... HealthLeaders-InterStudyNASHVILLE, Tenn., April 6 HealthLeaders-InterStudy, the leading ... between January 2008 and July 2008 enrollment in ... with a pharmacy benefit manager (PBM), also known ...
... Michael Paddock, CEO of Grants Office, LLC and a ... for on-camera and telephone interviews.Over the past several months, ... of knowledge and resources relating to the American Recovery ... knowledge of the various facets of ARRA funding (in ...
... April 6 The Quantum Group, Inc. (NYSE Amex: ... a Healthcare Services Organization (HSO), announced today that PWeR(TM) ... information platform and IBM hosted solution, is presenting in ... and Management Systems Society) Conference. The HIMSS09 conference ...
... those diagnosed with autism have underlying medical disorders that ... improvementATLANTA, April 6 A child is diagnosed with ... is more common in American children than cancer, diabetes, ... Control (CDC) estimates that one in every 94 boys ...
... Breakthrough Study Led by USC and Mayo ... Older adults can significantly improve their memory and performance ... according to a study published today in The Journal ... of 487 healthy older adults was led by researchers ...
Cached Medicine News:Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 2Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 3Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 4Health News:Enrollment in Employer-Contracted Pharmacy Benefit 'Carve-Out' Increased by More than Six Million Lives 2Health News:Grants Office CEO Available for Media Interviews on Stimulus Funding 2Health News:PWeR(TM) Presenting at HIMSS Conference in Chicago 2Health News:PWeR(TM) Presenting at HIMSS Conference in Chicago 3Health News:PWeR(TM) Presenting at HIMSS Conference in Chicago 4Health News:Alarming Rise in Autism Brings Hundreds of Parents, Researchers and Clinicians Together from Around the World to Atlanta April 17-19, 2009 2Health News:Computerized Brain Exercise Improves Memory 2
Inquire...
... The Trinity Biotech Captia™ Mumps IgG ... the detection and quantitative determination of IgG ... Individual serum specimens may be used for ... acute and convalescent, may be used to ...
... AUTOMATION, INC. (DAI) Mumps IgG ... intended for the detection and ... to Mumps virus in human ... be used for the determination ...
... Corporation announced the launch of the ... first bi-directional cooled-tip catheter available in the ... offers physicians the benefits of cooled ablation ... the Boston Scientific Blazer(R) catheter platform. ,Cooled ...
Medicine Products: